Retender radar: UK public contracts ending soon

Every contract in the catalogue with a published end date in the future, one row per contract (lot). A contract ending is a procurement starting, unless the buyer uses a published extension option, which the row shows. Frameworks and DPS are marked: what ends there is the vehicle, not one supplier’s contract.

When contracts end · Medical equipments, pharmaceuticals
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

A likely retender, not a certain one.

902 contracts end within 24 months, 1,006 in total · £854m published GBP value, exc. VAT, in the next 24 months (framework ceilings included, not a spend forecast).

  1. Next 3 months22
  2. 3–6 months277
  3. 6–12 months292
  4. 12–24 months311

By sector, next 24 months
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

A likely retender, not a certain one.

Contracts ending in the chosen window, by category.

CPV division of the procedure; a contract with several divisions counts in each.

Contracts ending in the next 24 months

Showing 976–990

  1. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Takeda UK Limited

    • Pharmaceutical products
    Contract value
    £56m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  2. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Bayer Plc

    • Pharmaceutical products
    Contract value
    £47m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  3. Ends · in 625 days

    Biologic and Biosimilar Medicines

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Roche Products Ltd

    • Pharmaceutical products
    Contract value
    £44m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-049b93
  4. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Janssen

    • Pharmaceutical products
    Contract value
    £36m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  5. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Amicus Therapeutics UK Operations Ltd

    • Pharmaceutical products
    Contract value
    £29m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  6. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Astellas Pharma Ltd

    • Pharmaceutical products
    Contract value
    £28m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  7. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Sanofi

    • Pharmaceutical products
    Contract value
    £28m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  8. Ends · in 625 days

    Biologic and Biosimilar Medicines

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Biogen Idec Ltd

    • Pharmaceutical products
    Contract value
    £23m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-049b93
  9. Ends · in 625 days

    Aseptics Medicines (Including Cytotoxics)

    Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts) · NHS & health · Nationwide (UK), Wales (Cymru)

    Incumbent: Janssen

    • Pharmaceutical products
    Contract value
    £22m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-0496e2
  10. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Eli Lilly & Company Ltd

    • Pharmaceutical products
    Contract value
    £22m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  11. Ends · in 625 days

    Antiretroviral Drugs

    Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts) · NHS & health · Wales (Cymru)

    Incumbent: Gilead Sciences Ltd

    • Pharmaceutical products
    Contract value
    £20m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac3a
  12. Ends · in 625 daysExtension option · up to 30 Jun 2030Panel · 10 suppliers

    Transitional Drugs 7

    Public Health Wales NHS Trust · Central government · Wales (Cymru)

    Panel: Amgen Ltd, Celix Pharma Ltd., Celltrion Healthcare Uk Ltd +7 more

    • Pharmaceutical products
    Contract value
    £17m
    Annual run-rate
    —panel, not one supplier
    Term
    1 Jul 2026 → 30 Jun 2028 · 1.9 yrs · up to 30 Jun 2030 with extensions
    Reference
    ocds-h6vhtk-067da4
  13. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: UCB Pharma

    • Pharmaceutical products
    Contract value
    £16m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  14. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Pfizer Ltd

    • Pharmaceutical products
    Contract value
    £13m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
  15. Ends · in 625 days

    Proprietary Drugs

    eTenderwales · Nationwide (UK), Wales (Cymru)

    Incumbent: Astra Zenica

    • Pharmaceutical products
    Contract value
    £12m
    Annual run-rate
    —start date not published
    Term
    Ends 30 Jun 2028 · start not published
    Reference
    ocds-h6vhtk-04ac47
How to read the radar
  • End date is the contract period end the buyer published on the notice. Contracts without an end date are not on the radar.
  • Extension option means the notice publishes a renewal or option clause; the buyer may extend instead of retendering. Hide them to see contracts that must be re-procured.
  • Incumbent is the supplier named on the award behind the contract. A panel (several suppliers on one award) is shown as a panel; no single incumbent is invented.
  • Annual run-rate = published GBP value ÷ published term, only for a single supplier, a term of six months or more and a plain contract (not a framework or DPS ceiling).
  • Counts are exact for the time-horizon and sector filters. With other filters, a result above 1,000 contracts shows as “1,000+”.
  • Source. Official UK procurement notices, reused under the Open Government Licence v3.0; the radar is rebuilt nightly. How we count: methodology.